Volume 10 -
MEJDS (2020) 10: 124 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hasan Larijani M, Hossein Sabet F, Borjali A. Effects of Acceptance and Commitment Therapy on Alexithymia in Patients with Multiple Sclerosis. MEJDS 2020; 10 :124-124
URL: http://jdisabilstud.org/article-1-1498-en.html
URL: http://jdisabilstud.org/article-1-1498-en.html
1- Faculty of Psychology and Education, Allameh Tabataba'i University
Abstract: (1993 Views)
Background & Objectives: Multiple Sclerosis (MS), as an autoimmune condition, is among the most prevalent neurological diseases in human. From the monolithic perspective of body, the abnormal immune responses in patients with MS might be accompanied by abnormal responses in the psychological level; in other words, they might have a personality trait at the psychological level involved with this condition. In this regard, a factor which might affect the deficits of immune system is alexithymia. The current study aimed to investigate the effects of Acceptance and Commitment Therapy (ACT) on alexithymia in patients with MS.
Methods: This was a quasi-experimental study with a pretest-posttest and two-month follow-up as well as a control group design. All patients with MS who attended to Alborz MS Society in April and May 2017 comprised the statistical population of this research. In total, 20 patients with MS were selected according to the study inclusion criteria via convenience sampling method. Then, they were randomly assigned into the experimental and control groups. Torento-20 (1994) Inventory was used for assessing alexithymia in the study participants. After determining the appointments, 10 two-hour sessions of ACT were performed for the experimental group. After the completion of the sessions, the questionnaire was completed again by both study groups. Finally, after two months, the follow-up phase was conducted in which the experimental and control groups re-completed the questionnaire. All obtained data were analyzed in SPSS by descriptive statistics of mean and standard deviation, as well as inferential statistics using Kolmogorov-Smirnov test to examine the assumption of normality of data; Levene's test to examine the assumption of equality of variances; repeated-measures Analysis of Variance (ANOVA), and Bonferroni follow-up test. The significance level was set at 0.05.
Results: The current study findings suggested that ACT significantly decreased alexithymia; this impact sustained until follow-up phase. Moreover, the effect of time was significant (η=0.510, p<0.001, F=18.75); accordingly, alexithymia significantly differed in three measurement stages. Additionally, the effect of group was significant which indicates that alexithymia influence was different between the test and control groups (η=0.440, p=0.001, F=14.52(. In addition to the two main effects of time and group, the interaction effect between time and group was also significant (η=0.531, p<0.001, F=20.36). Significant interaction between time and group highlights that the time variable interacted with the groups effect (test and control) and varied at different levels. Besides, following the significant difference between the values of pretest, posttest, and follow-up stages, Bonferroni post-hoc test was conducted to compare the mean values of the two stages to determine which difference between the two stages was statistically significant. There was also a significant difference between the mean scores of alexithymia in the pretest and posttest and follow-up stages.
Conclusion: The obtained data revealed that ACT effectively decreased alexithymia in the investigated patients with MS. As a result, this method could be implemented as an effective measure in healthcare centers. Clinical advisers, therapists, and psychologists could implement ACT to improve cognitive-emotional management and reduce alexithymia in patients with MS.
Methods: This was a quasi-experimental study with a pretest-posttest and two-month follow-up as well as a control group design. All patients with MS who attended to Alborz MS Society in April and May 2017 comprised the statistical population of this research. In total, 20 patients with MS were selected according to the study inclusion criteria via convenience sampling method. Then, they were randomly assigned into the experimental and control groups. Torento-20 (1994) Inventory was used for assessing alexithymia in the study participants. After determining the appointments, 10 two-hour sessions of ACT were performed for the experimental group. After the completion of the sessions, the questionnaire was completed again by both study groups. Finally, after two months, the follow-up phase was conducted in which the experimental and control groups re-completed the questionnaire. All obtained data were analyzed in SPSS by descriptive statistics of mean and standard deviation, as well as inferential statistics using Kolmogorov-Smirnov test to examine the assumption of normality of data; Levene's test to examine the assumption of equality of variances; repeated-measures Analysis of Variance (ANOVA), and Bonferroni follow-up test. The significance level was set at 0.05.
Results: The current study findings suggested that ACT significantly decreased alexithymia; this impact sustained until follow-up phase. Moreover, the effect of time was significant (η=0.510, p<0.001, F=18.75); accordingly, alexithymia significantly differed in three measurement stages. Additionally, the effect of group was significant which indicates that alexithymia influence was different between the test and control groups (η=0.440, p=0.001, F=14.52(. In addition to the two main effects of time and group, the interaction effect between time and group was also significant (η=0.531, p<0.001, F=20.36). Significant interaction between time and group highlights that the time variable interacted with the groups effect (test and control) and varied at different levels. Besides, following the significant difference between the values of pretest, posttest, and follow-up stages, Bonferroni post-hoc test was conducted to compare the mean values of the two stages to determine which difference between the two stages was statistically significant. There was also a significant difference between the mean scores of alexithymia in the pretest and posttest and follow-up stages.
Conclusion: The obtained data revealed that ACT effectively decreased alexithymia in the investigated patients with MS. As a result, this method could be implemented as an effective measure in healthcare centers. Clinical advisers, therapists, and psychologists could implement ACT to improve cognitive-emotional management and reduce alexithymia in patients with MS.
Type of Study: Original Research Article |
Subject:
Psychology
References
1. Sonkaya AR. Language Aspects of Patients with Multiple Sclerosis. Eurasian Journal of Medical Investigation. 2018;2(3):133–8. [DOI]
2. Chahraoui K, Duchene C, Rollot F, Bonin B, Moreau T. Longitudinal study of alexithymia and multiple sclerosis. Brain Behav. 2014;4(1):75–82. [DOI]
3. Etemadifar M, Sajjadi S, Nasr Z, Firoozeei TS, Abtahi S-H, Akbari M, et al. Epidemiology of multiple sclerosis in Iran: a systematic review. Eur Neurol. 2013;70(5–6):356–63. [DOI]
4. Sahraian MA, Khorramnia S, Ebrahim MM, Moinfar Z, Lotfi J, Pakdaman H. Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time. Eur Neurol. 2010;64(6):331–6. [DOI]
5. Hinkle JL, Cheever KH. Brunner & Suddarth’s Textbook of Medical-Surgical Nursing. Najafi Ghezjele T, Zeinali M, Slaemi S. (Persian translator). Tehran: Jamenegar Publication;2014.
6. Gilberstadt H, Farkas E. Another look at MMPI profile types in multiple sclerosis. J Consult Psychol. 1961;25:440–4. [DOI]
7. Kafetsios K, Hess U. Seeing mixed emotions: Alexithymia, emotion perception bias, and quality in dyadic interactions. Personality and Individual Differences. 2019;137:80–5. [DOI]
8. Kano M, Fukudo S. The alexithymic brain: the neural pathways linking alexithymia to physical disorders. Biopsychosoc Med. 2013;7:1. [DOI]
9. Dubey A, Pandey R, Mishra K. Role of emotion regulation difficulties and positive/negative affectivity in explaining alexithymia - health relationship: An overview. Indian Journal of Social Science Researches. 2010;7:20–31.
10. Bruce JM, Lynch SG. Personality traits in multiple sclerosis: association with mood and anxiety disorders. J Psychosom Res. 2011;70(5):479–85. [DOI]
11. Irani Barghi Z, Bakhti M, Baghyan MJ, Karami S. The Relationship between the Five Factors of Personality and Alexithymia with Mental Health in MS Patients. Journal of Health Psychology. 2014;3(10):64–79. [Persian] [Article]
12. Chahraoui K, Dieu E, Moreau T. Psychopathology of Alexithymia and Multiple Sclerosis. In: Brochet B. Neuropsychiatric Symptoms of Inflammatory Demyelinating Diseases. Springer; 2015. pp:195–211.
13. Enayati A, La’li M, Najafi MR. Rabete beyn Alexithymia ba shakhes salamat ravan dar bimaran MS shahr Isfahan [Relationship between Alexithymia and Mental Health Index in MS patients in Isfahan]. In: First International Congress of Psychology Society of Iran [Internet]. Tehran, Iran; 2015. [Persian] [Article]
14. Sonkaya AR. The relationship between alexithymia and depression in patients with multiple sclerosis. Eurasian Journal of Medical Investigation. 2019;3(2):196–72. [DOI]
15. Spek V, Nyklícek I, Cuijpers P, Pop V. Alexithymia and cognitive behaviour therapy outcome for subthreshold depression. Acta Psychiatr Scand. 2008;118(2):164–7. [DOI]
16. Baigan K, Khoshkonesh A, Habibi Askarabad M, Fallahzade H. Effectiveness of dialectical behavioral group therapy in alexithymia, stress, and diabetes symptoms among type 2 diabetes patients. Journal of Diabetes Nursing. 2016;4(3):8–18. [Persian] [Article]
17. Heydari RS, Dastjerdi R, Salehi Fadardi J. The effects of emotion focused therapy on reducing alexithymia and OCD symptoms. Trends in Life Sciences. 2014;3(5):100–9.
18. Norman H, Marzano L, Coulson M, Oskis A. Effects of mindfulness-based interventions on alexithymia: A systematic review. Evid Based Mental Health. 2019;22(1):36–43. [DOI]
19. Moriguchi Y, Ohnishi T, Lane RD, Maeda M, Mori T, Nemoto K, et al. Impaired self-awareness and theory of mind: an fMRI study of mentalizing in alexithymia. Neuroimage. 2006;32(3):1472–82. [DOI]
20. Hayes SC. Acceptance and commitment therapy, relational frame theory, and the third wave of behavioral and cognitive therapies. BehTher. 2004;35(4):639–65. [DOI]
21. Zamani E, Moatamedy A, Bakhtiari M. The effectiveness of acceptance and commitment group therapy on anxiety in multiple sclerosis. Journal of Health Psychology. 2017;5(20):152–67. [Persian] [Article]
22. Proctor BJ, Moghaddam NG, Evangelou N, das Nair R. Telephone-supported acceptance and commitment bibliotherapy for people with multiple sclerosis and psychological distress: A pilot randomised controlled trial. Journal of Contextual Behavioral Science. 2018;9:103–9. [Persian] [DOI]
23. Sheppard SC, Forsyth JP, Hickling EJ, Bianchi J. A novel application of acceptance and commitment therapy for psychosocial problems associated with multiple sclerosis. international Journal of MS Care. 2010;12(4):200–6. [DOI]
24. Gillanders S, Gillanders D. An Acceptance and Commitment Therapy intervention for a woman with secondary progressive multiple sclerosis and a history of childhood trauma. Neuro-disabilty and Psychotherapy. 2014;2(1–2):19–40.
25. Mashhadi A, Neghabi M, Teymouri S. Asarbakhshi darman groohi mobtani bar paziresh va ta’ahod dar naresaie hayajani fozoon koneshi bozorgsalan va kahesh alayem ekhtelal naresaie tavajoh [The effectiveness of group acceptance and commitment therapy on reducing symptoms of alexithymia and impulsivity/ attention deficit]. In: The 3nd National Conference on Research and Treatment in Clinical Psychology. Torbat–Jam, Iran: Azad Islamic University; 2016. [Persian]
26. Darvish Baseri L, DashtBozorgi Z. Effectiveness of group therapy based on acceptance and commitment on cognitive emotion regulation and alexithymia of patients with type 2 diabetes. Iranian Journal of Psychiatric Nursing. 2017;5(1):7–14. [Persian] [DOI]
27. Tilaki M, Taher M, Mojarrad A, Jafari Sani B. Efficacy of acceptance and commitment therapy on psychological flexibility and alexithymia of women with chronic pain. Journal of Psychological Studies. 2018;14(3):163–78. [Persian] [DOI]
28. Izadi R, Abedi MR. Acceptance Commitment Therapy ACT. Tehran: Jungle Publication; 2014. pp:71–141. [Persian]
29. Bagby RM, Parker JD, Taylor GJ. The twenty-item Toronto Alexithymia Scale--I. Item selection and cross-validation of the factor structure. J Psychosom Res. 1994;38(1):23–32. [DOI]
30. Besharat MA. Reliability and factorial validity of a Farsi version of the 20-item Toronto Alexithymia Scale with a sample of Iranian students. Psychol Rep. 2007;101(1):209–20. [DOI]
31. Bach PA, Moran DJ. ACT in Practice: Case Conceptualization in Acceptance and Commitment Therapy. Kian Rad N, Kamali S. (Persain translator). Tehran: Arjmand Publication;2014. pp:20–4.
32. Venta A, Hart J, Sharp C. The relation between experiential avoidance, alexithymia and emotion regulation in inpatient adolescents. Clin Child Psychol Psychiatry. 2013;18(3):398–410. [DOI]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
